Related Experiment Video
Updated: Sep 20, 2025

Isolation and Analysis of Aortic Arch and Root Lesions in an Atherosclerotic Mouse Model
Published on: February 14, 2025
Animal Models of Atherosclerosis-Supportive Notes and Tricks of the Trade
Anton Gisterå1, Daniel F J Ketelhuth1,2, Stephen G Malin1
1Cardiovascular Medicine, Department of Medicine Solna, Karolinska Institutet and Center for Molecular Medicine, Karolinska University Hospital, Stockholm, Sweden (A.G., D.F.J.K., S.G.M., G.K.H.).
Insights
This review examines animal models for atherosclerosis, a major cause of death. Understanding immune-vascular interactions in these models is crucial for developing future cardiovascular disease treatments.
Area of Science:
- Cardiovascular Research
- Immunology
- Animal Modeling
Background:
- Atherosclerotic cardiovascular disease is a leading global cause of mortality.
- Cholesterol and inflammation are key drivers of atherosclerosis, with apolipoprotein B lipoproteins triggering vascular inflammation.
- Current treatments lack specificity for vascular inflammation, necessitating further in vivo research.
Purpose of the Study:
- To provide a contemporary understanding of vascular disease models by integrating existing knowledge with recent findings.
- To critically evaluate the advantages and disadvantages of various animal models used in atherosclerosis research.
- To discuss the intricate relationship between cholesterol metabolism, immune responses, and vascular system adaptations.
Main Methods:
- Review and synthesis of existing literature on atherosclerosis models.
- Comparative analysis of different animal models, highlighting their strengths and weaknesses.
- Discussion of the interplay between key biological processes in disease development.
Main Results:
- Identification of limitations in current atherosclerosis models.
- Emphasis on the complex interactions between cholesterol, immunity, and the vasculature.
- Highlighting the need for improved and diverse experimental approaches.
Conclusions:
- Current animal models have limitations that may hinder progress in understanding atherosclerosis.
- Developing and utilizing improved or novel models is essential for advancing cardiovascular disease research.
- Enhanced models could accelerate the development of future diagnostics and therapeutics for cardiovascular diseases.
Abstract:
Atherosclerotic cardiovascular disease is a major cause of death among humans. Animal models have shown that cholesterol and inflammation are causatively involved in the disease process. Apolipoprotein B-containing lipoproteins elicit immune reactions and instigate inflammation in the vessel wall. Still, a treatment that is specific to vascular inflammation is lacking, which motivates continued in vivo investigations of the immune-vascular interactions that drive the disease. In this review, we distill old notions with emerging concepts into a contemporary understanding of vascular disease models. Pros and cons of different models are listed and the complex integrative interplay between cholesterol homeostasis, immune activation, and adaptations of the vascular system is discussed. Key limitations with atherosclerosis models are highlighted, and we suggest improvements that could accelerate progress in the field. However, excessively rigid experimental guidelines or limiting usage to certain animal models can be counterproductive. Continued work in improved models, as well as the development of new models, should be of great value in research and could aid the development of cardiovascular disease diagnostics and therapeutics of the future.
More Related Videos
Related Concept Videos
Atherosclerosis III: Management
Atherosclerosis II: Clinical Manifestations and Diagnostic Tests
Atherosclerosis IV: Nursing Management
Atherosclerosis I: Introduction
Coronary Artery Disease IV: Preventive Measures

